Data / Research funding / Allergic Rhinitis (Hay Fever)
Allergic Rhinitis (Hay Fever): 17 NIH awards ($24.7M) to 14 organizations
17 NIH awards ($24.7M) in the NIH spending category Allergic Rhinitis (Hay Fever), to 14 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
17 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Mechanistic clinical trial of blocking the IL-4/13 axis in asthmatics precision phenotyped in an aeroallergen challenge chamber before, during and after receipt of dupilumab | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,232,798 | August 18, 2022 | May 31, 2027 | AHUJA, SUNIL K | reporter.nih.gov |
| Mechanisms of Allergen-induced Type 2 Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,733,347 | November 1, 2019 | April 30, 2028 | KITA, HIROHITO | reporter.nih.gov |
| The Neural Mechanism of Respiratory Allergies and Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,585,630 | May 14, 2021 | April 30, 2027 | LIU, QIN | reporter.nih.gov |
| Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,045,450 | February 10, 2019 | January 31, 2026 | BRASIER, ALLAN R. | reporter.nih.gov |
| Development of a new TLR4 agonist for the treatment of Allergic Rhinitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,836,453 | September 1, 2021 | August 31, 2023 | KHALAF, JUHIENAH | reporter.nih.gov |
| In vivo Imaging and Quantification of Cilia Beating Dynamics Using Phase-Resolved Optical Imaging Technology | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $1,750,640 | July 1, 2020 | March 31, 2026 | CHEN, ZHONGPING | reporter.nih.gov |
| Epidemiology of multimorbid pediatric atopic and airway diseases and the impact of prenatal maternal environmental exposures and placental epigenetics | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $1,677,190 | September 1, 2023 | May 31, 2025 | STRAUGHEN, JENNIFER K. | reporter.nih.gov |
| Role of Cytosolic DNA-multiprotein Interactome in Allergic Airway Inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,579,503 | January 10, 2019 | December 31, 2024 | HAZRA, TAPAS K | reporter.nih.gov |
| REACH-SPIROMICS: Research on Environmental Aeroallergens, COPD, and Health in SPIROMICS | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,340,292 | August 1, 2025 | May 31, 2029 | KAUFMAN, JOEL DANIEL | reporter.nih.gov |
| Mechanisms of Antigen-Induced Tolerance in the Lung | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,120,442 | June 12, 2024 | April 30, 2029 | RAY, ANURADHA | reporter.nih.gov |
| Clinical prediction and epigenetic regulation of asthma and rhinitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $638,879 | February 10, 2021 | September 1, 2023 | WANG, ALBERTA L. | reporter.nih.gov |
| The effect of early-life nasal colonization with Lactobacillus on the development of the local immune response and the later onset of recurrent wheeze, childhood asthma, and allergic rhinitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $538,393 | August 15, 2019 | July 31, 2025 | ROSAS-SALAZAR, CHRISTIAN | reporter.nih.gov |
| Epidemiology of multimorbid pediatric atopic and airway diseases and the impact of prenatal maternal environmental exposures and placental epigenetics | NIH | Office of the Director, National Institutes of Health | 2025 | $466,781 | September 1, 2023 | May 31, 2030 | STRAUGHEN, JENNIFER K. | reporter.nih.gov |
| A new deep learning approach to probe the molecular basis of inhalation allergens | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $440,000 | July 1, 2025 | June 30, 2027 | BRAUN, WERNER A | reporter.nih.gov |
| Dysregulated sensing of invertebrate tropomyosin through dectin-1 confers susceptibility to type-2-mediated allergic diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $409,375 | June 1, 2017 | May 31, 2023 | LAJOIE, STEPHANE | reporter.nih.gov |
| Establishing the role of the upper airway mycobiome on childhood respiratory outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $212,500 | June 1, 2020 | May 31, 2023 | DAS, SUMAN RANJAN | reporter.nih.gov |
| Improved estimation of pollen exposure, mixtures, and risk of respiratory illness | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $97,948 | March 12, 2024 | March 11, 2027 | LAPPE, BROOKE | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Texas HLTH Science Center | San Antonio, TX | 1 | $5.2 million | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 1 | $2.7 million | 0 | $0 |
| Washington University | Saint Louis, MO | 1 | $2.6 million | 0 | $0 |
| Henry Ford Health System | Detroit, MI | 2 | $2.1 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 1 | $2 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 2 | $2 million | 0 | $0 |
| Inimmune Corporation | Missoula, MT | 1 | $1.8 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 1 | $1.8 million | 0 | $0 |
| University of Washington | Seattle, WA | 1 | $1.3 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 1 | $1.1 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 2 | $750,893 | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 1 | $638,879 | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 1 | $409,375 | 0 | $0 |
| Emory University | Atlanta, GA | 1 | $97,948 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 8 | $5,603,430 | 0 | $0 |
| 2024 | 7 | $4,257,978 | 0 | $0 |
| 2023 | 8 | $4,856,426 | 0 | $0 |
| 2022 | 7 | $4,087,065 | 0 | $0 |
| 2021 | 10 | $5,900,722 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 8 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 8 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.